“For the past several years, I have been impressed with SI-BONE’s relentless focus on building clinical evidence and providing leadership through their educational efforts and I am looking forward to working with Jeff Dunn and the SI-BONE team to accelerate the adoption of this foundational approach to helping patients,” said Mr. Watson.
He is the managing director for Fidelity and has previous experience as the founder and CEO of HealthMine, a population health management company. He also has previous executive roles with UnitedHealthcare and Aetna.
“We are happy to welcome Martin to our board of directors,” said SI-BONE President and CEO Jeffrey Dunn. “Martin’s extensive experience working with large and small commercial health plans will provide significant insight and guidance for us as we continue to expand our portfolio of clinical evidence to support further adoption of iFuse among commercial health plans throughout the U.S.”
More articles on orthopedic devices:
7 important trends in the global orthobiologics market
OMNI Orthopaedics gets $6M financing: 5 things to know
Top 3 cities for pharmaceutical payments to physicians
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
